Literature DB >> 25754077

Synthesis and crystal structure of new heterocyles derived from saccharin and uracil carrying 1,2,4-oxadiazolylmethyl group.

Yaşar Dürüst1, Besra Özer, Benson M Kariuki, Benson M Cariuki.   

Abstract

Saccharin, uracil, and 1,2,4-oxadiazole heterocyles are important in terms of exhibiting various biological acitivities. In this work, four series of 1,2,4-oxadiazolylmethyl-substituted saccharin, and uracil derivatives are synthesized and their structures are identified by means of spectral/physical characteristics. The first series are oxadiazolylmethyl-substituted saccharins. The second one is oxadiazole-substituted uracils which are obtained as a separable mixture of both mono- and bis-substituted end products. Third series is obtained from 5-amino uracil and chloromethyl oxadiazoles. The fourth group is oxadiazolyl methyl-substituted imino uracils. The structures of some title compounds are also confirmed by X-ray diffraction data.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25754077     DOI: 10.1007/s11030-015-9577-3

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  10 in total

Review 1.  Peptidomimetics and peptide backbone modifications.

Authors:  Jung-Mo Ahn; Nicholas A Boyle; Mary T MacDonald; Kim D Janda
Journal:  Mini Rev Med Chem       Date:  2002-10       Impact factor: 3.862

2.  Design and synthesis of potent, non-peptidic inhibitors of HPTPbeta.

Authors:  Kande K D Amarasinghe; Artem G Evdokimov; Artem G Evidokimov; Kevin Xu; Cynthia M Clark; Matthew B Maier; Anil Srivastava; Anny-Odile Colson; Gina S Gerwe; George E Stake; Brian W Howard; Matthew E Pokross; Jeffrey L Gray; Kevin G Peters
Journal:  Bioorg Med Chem Lett       Date:  2006-06-12       Impact factor: 2.823

3.  Synthesis, anti-inflammatory and antimicrobial activities of new 1,2,4-oxadiazoles peptidomimetics.

Authors:  A C Leite; R F Vieira; A G de Wanderley; P Afiatpour; E C Ximenes; R M Srivastava; C F de Oliveira; M V Medeiros; E Antunes; D J Brondani
Journal:  Farmaco       Date:  2000 Nov-Dec

4.  Uracils as potent antagonists of the human gonadotropin-releasing hormone receptor without atropisomers.

Authors:  Zhiqiang Guo; Yongsheng Chen; Charles Q Huang; Timothy D Gross; Joseph Pontillo; Martin W Rowbottom; John Saunders; Scott Struthers; Fabio C Tucci; Qiu Xie; Warren Wade; Yun-Fei Zhu; Dongpei Wu; Chen Chen
Journal:  Bioorg Med Chem Lett       Date:  2005-05-16       Impact factor: 2.823

5.  Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.

Authors:  L J Street; R Baker; T Book; C O Kneen; A M MacLeod; K J Merchant; G A Showell; J Saunders; R H Herbert; S B Freedman
Journal:  J Med Chem       Date:  1990-10       Impact factor: 7.446

6.  Synthesis of 3-aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor properties.

Authors:  Natércia M Miranda Bezerra; Shalom P De Oliveira; Rajendra M Srivastava; Joel R Da Silva
Journal:  Farmaco       Date:  2005-10-20

7.  Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines.

Authors:  F Watjen; R Baker; M Engelstoff; R Herbert; A MacLeod; A Knight; K Merchant; J Moseley; J Saunders; C J Swain
Journal:  J Med Chem       Date:  1989-10       Impact factor: 7.446

8.  Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.

Authors:  G D Diana; D L Volkots; T J Nitz; T R Bailey; M A Long; N Vescio; S Aldous; D C Pevear; F J Dutko
Journal:  J Med Chem       Date:  1994-07-22       Impact factor: 7.446

9.  Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activity.

Authors:  Chen Chen; Yongsheng Chen; Joseph Pontillo; Zhiqiang Guo; Charles Q Huang; Dongpei Wu; Ajay Madan; Takung Chen; Jenny Wen; Qiu Xie; Fabio C Tucci; Martin Rowbottom; Yun-Fei Zhu; Warren Wade; John Saunders; Haig Bozigian; R Scott Struthers
Journal:  Bioorg Med Chem Lett       Date:  2008-04-26       Impact factor: 2.823

10.  Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor.

Authors:  B S Orlek; F E Blaney; F Brown; M S Clark; M S Hadley; J Hatcher; G J Riley; H E Rosenberg; H J Wadsworth; P Wyman
Journal:  J Med Chem       Date:  1991-09       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.